Acadia Healthcare Company, Inc.
NASDAQ:ACHCMedical - Care Facilities
+$1.14 today
- Market cap
- $3.49B
- Beta
- 0.69
- P/E (TTM)
- -2.0
- EPS (TTM)
- -$12.23
Volume 1.52M
Average 2.82M
ACHC EBITDA Margin
EBITDA as a percentage of revenue.
Acadia Healthcare Company, Inc.NASDAQ: ACHC
EBITDA Margin · Q3 FY2026 · quarter ended Sep 2026
EBITDA Margin widens to 15.9%
EBITDA Margin was 15.9% in Q3 FY2026, up 1.4 pp from a year earlier. On a trailing-twelve-month basis it was -19.5%, down 33.4 pp year over year. Over 3 fiscal years it narrowed by 43.8 pp.
Context
- EBITDA Margin widened in 1 of the last 3 fiscal years.
- FY2025 was the lowest level in the 4 fiscal years shown.
What to watch
Whether EBITDA Margin reaches the consensus estimate from 10 analysts of 16.0% for the fiscal year ending Dec 2026, up from -22.3% in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterSep 2026
- 15.9%-4.4 pp QoQ
- Last fiscal yearDec 2025
- -22.3%-41.5 pp YoY
- LTMSep 2026
- -19.5%-33.4 pp YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +1.4 pp | +148.4 pp | +147.0 pp |
| 1 year | -41.5 pp | +38.2 pp | +79.8 pp |
| 3 years | -43.8 pp | +42.0 pp | +85.8 pp |
| 5 years | — | — | |
| 10 years | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- -22.3%
- Year-over-year change
- -41.5pp
| Period | Period end | EBITDA Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | -22.3% | -41.5pp |
| FY2024 | 2024-12-31 | 19.3% | +12.8pp |
| FY2023 | 2023-12-31 | 6.5% | -15.1pp |
| FY2022 | 2022-12-31 | 21.5% | +1.7pp |
| FY2021 | 2021-12-31 | 19.9% | — |
EBITDA Margin vs competitors
How ACHC compares with its peers on the latest reported figures
- ACHC's LTM Sep 2026 EBITDA Margin of -19.5% is the lowest of the 3 companies compared; the peer median is 11.9%.
- Its year-over-year change of -33.4 pp is the lowest of 3, against a peer median of +2.4 pp.
- Over three fiscal years its change of -43.8 pp compares with a peer median of +13.1 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Jun 2026 | 15.6% | +0.8 pp | +4.0 pp | |
| LTM Jun 2026 | 8.3% | +4.0 pp | +22.2 pp | |
| LTM Sep 2026 | -19.5% | -33.4 pp | -43.8 pp | |
| Peer median (excluding ACHC) | 11.9% | +2.4 pp | +13.1 pp | |
Competitors are the stored peer set for ACHC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 2.31B | 2.61B | 2.93B | 3.15B | 3.31B |
| Cost of Revenue | 90.7M | 100.2M | 2.25B | 2.44B | 2.73B |
| Gross Profit | 2.22B | 2.51B | 682.61M | 711.98M | 583.44M |
| Gross Margin | 96.1% | 96.2% | 23.3% | 22.6% | 17.6% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 1.42B | 1.6B | 176.01M | 189.71M | 195.48M |
| Operating Expenses | 1.81B | 2.04B | 176.01M | 189.71M | 195.48M |
| Depreciation & Amortization | 106.72M | 117.77M | 132.35M | 149.6M | 189.25M |
| EBITDA | 459.47M | 561.67M | 189.11M | 607.84M | (737.83M) |
| EBITDA Margin | 19.9% | 21.5% | 6.5% | 19.3% | -22.3% |
| Operating Income | 414.47M | 467.7M | 506.6M | 522.28M | 387.97M |
| Operating Margin | 17.9% | 17.9% | 17.3% | 16.6% | 11.7% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 76.99M | 69.76M | 82.13M | 116.37M | 138.86M |
| Other Income / Expenses | (138.71M) | (93.55M) | (531.96M) | (180.4M) | (1.45B) |
| Income Before Tax | 275.76M | 374.14M | (25.36M) | 341.88M | (1.07B) |
| Pre-Tax Margin | 11.9% | 14.3% | -0.9% | 10.8% | -32.2% |
| Income Tax Expense | 67.56M | 94.11M | (9.7M) | 77.4M | 25.98M |
| Net Income | 190.64M | 273.14M | (21.67M) | 255.61M | (1.1B) |
| Net Margin | 8.2% | 10.5% | -0.7% | 8.1% | -33.3% |
| EPS (Basic) | 2.15 | 3.05 | (0.24) | 2.79 | (12.16) |
| EPS (Diluted) | 2.10 | 2.98 | (0.24) | 2.78 | (12.16) |
| Weighted Avg Shares | 88.77M | 89.68M | 90.95M | 91.62M | 90.71M |
| Weighted Avg Shares (Diluted) | 90.79M | 91.56M | 90.95M | 92.06M | 90.71M |
Acadia Healthcare Company, Inc.
NASDAQ:ACHC
Intrinsic Alpha fair value
Locked
Current Price
$37.59
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.